Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Duane Schulthess"'
Autor:
Duane Schulthess, Harry P. Bowen, Robert Popovian, Daniel Gassull, Augustine Zhang, Joe Hammang
Publikováno v:
Therapeutic innovationregulatory science. 57(1)
Objectives There remains ongoing debate regarding the relative efficacy of public (NIH) and private sector funding in bringing biopharmaceutical innovations to market. This paper investigates the significance of each party’s level of funding for ob
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5c6d964fbf9b2ca495ecb1ead05bc1c
https://pubmed.ncbi.nlm.nih.gov/36112306
https://pubmed.ncbi.nlm.nih.gov/36112306
Autor:
Duane Schulthess, Harry P. Bowen, Robert Popovian, Daniel Gassull, Augustine Zhang, Joe Hammang
Publikováno v:
Therapeutic Innovation & Regulatory Science. 57:170-171
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0a1f5967eb78bf6be85008bf8ea5bde3
https://doi.org/10.1007/s43441-022-00461-6
https://doi.org/10.1007/s43441-022-00461-6
Autor:
Madan Jagasia, Brian S. Rothman, Leeland Ekstrom, Anna Ludlow, Daniel Gassull, Pieter ten Have, Monique Minnema, Duane Schulthess, Yiyang Wu, Amr Makady
Publikováno v:
BMJ Evidence-Based Medicine
With the increasing use of new regulatory tools, like the Food and Drug Administration’s breakthrough designation, there are increasing challenges for European health technology assessors (HTAs) to make an accurate assessment of the long-term value
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::898fb7441d4c9bfe7f4564033304c045
https://doi.org/10.1136/bmjebm-2019-111226
https://doi.org/10.1136/bmjebm-2019-111226
Autor:
Duane Schulthess
Publikováno v:
Medicine and Clinical Science. 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::da0929b1e94fa4f54ef8c2e5151fe3f3
https://doi.org/10.33425/2690-5191.1028
https://doi.org/10.33425/2690-5191.1028
Publikováno v:
Therapeutic innovationregulatory science. 53(6)
According to Secretary Azar of Health and Human Services, implementing international reference pricing (IPI) in Medicare Part B will have minimal impacts. He has stated, "These savings, while substantial for American patients and taxpayers, cannot po
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f89a8bedaf7a2665b9330294304b405
https://pubmed.ncbi.nlm.nih.gov/31771359
https://pubmed.ncbi.nlm.nih.gov/31771359
Autor:
Murray Lumpkin, Mark R. Trusheim, Gigi Hirsch, Richard Bergstrom, Pamela Gavin, Nathalie Seigneuret, Anton Hoos, Magda Chlebus, Michel Goldman, Karin Van Baelen, Duane Schulthess, Lynn G. Baird, Sarah Garner, Thomas F. Unger
Publikováno v:
Therapeutic innovationregulatory science. 50(3)
After nearly a decade of discussion, analysis, and development, the Medicines Adaptive Pathways to Patients (MAPPs) initiative is beginning to see acceptance from regulators, industry, patients, and payers, with the first live pilot project initiated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e0779b5e220d87c761d1b6702f4d8c2
https://pubmed.ncbi.nlm.nih.gov/30227070
https://pubmed.ncbi.nlm.nih.gov/30227070
Publikováno v:
Drug discovery today. 23(3)
The objective of this paper is to identify the extent to which real world data (RWD) is being utilized, or could be utilized, at scale in drug development. Through screening peer-reviewed literature, we have cited specific examples where RWD can be u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e317414b034751d94bf3923a5668581
https://pubmed.ncbi.nlm.nih.gov/29294362
https://pubmed.ncbi.nlm.nih.gov/29294362
Publikováno v:
Health Policy and Technology. 2:181-187
The Whole-Body Magnetic Resonance Angiography (WBMRA) consists of a contrast-enhanced Magnetic Resonance Angiogram (MRA) scan of the entire body in a single step. In the diagnosis of cardiovascular co-morbidities in Peripheral Arterial Disease (PAD),
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a16aea420dc0ab88aa2c1333b2431bb6
https://doi.org/10.1016/j.hlpt.2013.08.003
https://doi.org/10.1016/j.hlpt.2013.08.003
Autor:
Walter Van Dyck, Nuala Moran, Gergely Vértes, Erik Tambuyzer, Muhilan Palaniappan, Duane Schulthess, Daniel Gassull, Prateek Jain, Richard Hudson
Publikováno v:
Health Policy and Technology. 1:173-177
This study is a cost-analysis that calculates the impact of three interventions for patients identified as ‘at risk’ for Acute Coronary Syndrome - a cardio-vascular exercise programme, point-of-care digital diagnostics, and telemonitoring adheren
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ba94895223da427d9a5160c5ae664672
https://doi.org/10.1016/j.hlpt.2012.07.002
https://doi.org/10.1016/j.hlpt.2012.07.002
Autor:
Gergely Vértes, Richard Hudson, Erik Tambuyzer, Walter Van Dyck, Nuala Moran, Daniel Gassull, Prateek Jain, Muhilan Palaniappan, Duane Schulthess
Publikováno v:
Health Policy and Technology. 1:63-68
Through stratification, this simulation shows that there is great potential to improve the efficiency of treating breast cancer. By segmenting the female population at the age of 50 based on family history and genetic testing, our model shows a reduc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6bcf37bb059715953b5e35145e7c73ca
https://doi.org/10.1016/j.hlpt.2012.04.006
https://doi.org/10.1016/j.hlpt.2012.04.006